658 related articles for article (PubMed ID: 33077325)
1. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies.
Mhaidly R; Mechta-Grigoriou F
Semin Immunol; 2020 Apr; 48():101417. PubMed ID: 33077325
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
3. Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer.
Mhaidly R; Mechta-Grigoriou F
Immunol Rev; 2021 Jul; 302(1):259-272. PubMed ID: 34013544
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
5. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts.
Ziani L; Chouaib S; Thiery J
Front Immunol; 2018; 9():414. PubMed ID: 29545811
[TBL] [Abstract][Full Text] [Related]
8. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
Monteran L; Erez N
Front Immunol; 2019; 10():1835. PubMed ID: 31428105
[TBL] [Abstract][Full Text] [Related]
9. From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts.
Arpinati L; Scherz-Shouval R
Trends Cancer; 2023 May; 9(5):421-443. PubMed ID: 36870916
[TBL] [Abstract][Full Text] [Related]
10. TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts.
Perez-Penco M; Lara de la Torre L; Lecoq I; Martinenaite E; Andersen MH
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38417917
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.
Chen PY; Wei WF; Wu HZ; Fan LS; Wang W
Front Immunol; 2021; 12():671595. PubMed ID: 34305902
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
Pradip D; Jennifer A; Nandini D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
[TBL] [Abstract][Full Text] [Related]
13. Local immune response in cutaneous basal cell carcinoma.
Omland SH
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975891
[TBL] [Abstract][Full Text] [Related]
14. HIPK2 role in the tumor-host interaction: Impact on fibroblasts transdifferentiation CAF-like.
Garufi A; Traversi G; Cirone M; D'Orazi G
IUBMB Life; 2019 Dec; 71(12):2055-2061. PubMed ID: 31414572
[TBL] [Abstract][Full Text] [Related]
15. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.
Costa A; Kieffer Y; Scholer-Dahirel A; Pelon F; Bourachot B; Cardon M; Sirven P; Magagna I; Fuhrmann L; Bernard C; Bonneau C; Kondratova M; Kuperstein I; Zinovyev A; Givel AM; Parrini MC; Soumelis V; Vincent-Salomon A; Mechta-Grigoriou F
Cancer Cell; 2018 Mar; 33(3):463-479.e10. PubMed ID: 29455927
[TBL] [Abstract][Full Text] [Related]
17. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
Piper M; Mueller AC; Karam SD
Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
19. Dissecting tumor microenvironment heterogeneity in syngeneic mouse models: insights on cancer-associated fibroblast phenotypes shaped by infiltrating T cells.
Carretta M; Thorseth ML; Schina A; Agardy DA; Johansen AZ; Baker KJ; Khan S; Rømer AMA; Fjæstad KY; Linder H; Kuczek DE; Donia M; Grøntved L; Madsen DH
Front Immunol; 2023; 14():1320614. PubMed ID: 38259467
[TBL] [Abstract][Full Text] [Related]
20. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1.
Cohen N; Shani O; Raz Y; Sharon Y; Hoffman D; Abramovitz L; Erez N
Oncogene; 2017 Aug; 36(31):4457-4468. PubMed ID: 28368410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
